Study of HRS-1780 for Primary Aldosteronism
Part of Hormones & metabolism clinical trials.
This trial tests a new drug called HRS-1780 for people with primary aldosteronism, a condition that causes high blood pressure. The goal is to see if the drug is safe and effective in lowering blood pressure and managing the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure).
- You are either not taking blood pressure medication or have been on a stable dose for a while.
- You are willing to avoid pregnancy and use effective birth control during the study and for 4 weeks after your last dose.
- You do not have severe kidney disease (eGFR below 30) or a history of certain health problems like recent stroke, heart attack, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.
This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.
This trial tests a drug called finerenone for people with a specific cause of high blood pressure (primary aldosteronism). It aims to see if finerenone can help lower blood pressure and improve hormone levels better than current care.
This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.
This study tests a new medication (QLS1410) for primary aldosteronism, a condition where the body produces too much of a hormone called aldosterone, causing high blood pressure. The trial will see if this drug can help control blood pressure better than current treatments.
This trial studies whether a specific treatment (related to spironolactone/aldosterone support) can improve how well your blood vessels work in people with primary aldosteronism. It may help reduce blood pressure risk by improving blood vessel health.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.